Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: ODDO BHF Cuts IAG To Neutral From Buy

Thu, 30th Apr 2020 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

ODDO BHF CUTS INTERNATIONAL CONSOLIDATED AIRLINES GROUP TO 'NEUTRAL' (BUY) - PRICE TARGET 2.80 (3.50) EUR

----------

LIBERUM CUTS RIGHTMOVE PRICE TARGET TO 470 (570) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BT GROUP PRICE TARGET TO 110 (146) PENCE - 'SELL'

----------

DEUTSCHE BANK RAISES COMPASS GROUP PRICE TARGET TO 1506 (1200) PENCE - 'HOLD'

----------

HSBC CUTS SEGRO PRICE TARGET TO 833 (890) PENCE - 'HOLD'

----------

HSBC CUTS LAND SECURITIES PRICE TARGET TO 679 (897) PENCE - 'HOLD'

----------

JPMORGAN CUTS LAND SECURITIES PRICE TARGET TO 685 (775) PENCE - 'NEUTRAL'

----------

HSBC CUTS BRITISH LAND CO TO 'HOLD' ('BUY') - TARGET 385 (643) PENCE

----------

JPMORGAN CUTS BRITISH LAND CO PRICE TARGET TO 460 (490) PENCE - 'NEUTRAL'

----------

HSBC RAISES ASTRAZENECA PRICE TARGET TO 6690 (6450) PENCE - 'REDUCE'

----------

CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 9000 (8500) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1550 (1450) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN CUTS STANDARD CHARTERED PRICE TARGET TO 820 (850) PENCE - 'BUY'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 4730 (4870) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES POLYMETAL PRICE TARGET TO 1800 (1500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLENCORE PRICE TARGET TO 170 (140) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS FRESNILLO PRICE TARGET TO 550 (600) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BHP PRICE TARGET TO 1830 (1820) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ANTOFAGASTA PRICE TARGET TO 700 (660) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES ANGLO AMERICAN PRICE TARGET TO 2500 (2300) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS INTERTEK PRICE TARGET TO 4400 (4550) PENCE - 'NEUTRAL'

----------

SHORE CAPITAL RESUMES J SAINSBURY WITH 'HOLD'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 3522 (3998) PENCE

----------

JEFFERIES CUTS NEXT PRICE TARGET TO 5600 (6700) PENCE - 'HOLD'

----------

JPMORGAN RAISES WPP PRICE TARGET TO 750 (630) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

JPMORGAN RAISES MITCHELLS & BUTLERS TO 'OVERWEIGHT' ('NEUTRAL') TARGET 340(490)P

----------

JPMORGAN CUTS MARSTONS PRICE TARGET TO 57 (128) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS JD WETHERSPOON PRICE TARGET TO 600 (1100) PENCE - 'UNDERWEIGHT'

----------

CITIGROUP CUTS TUI PRICE TARGET TO 125 (260) PENCE - 'SELL'

----------

PEEL HUNT CUTS GENUS TO 'HOLD' ('BUY')

----------

DEUTSCHE BANK RAISES IMI PRICE TARGET TO 1000 (940) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SYNTHOMER PRICE TARGET TO 300 (265) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 317 (274) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES ELEMENTIS PRICE TARGET TO 100 (75) PENCE - 'BUY'

----------

BERENBERG RAISES PLUS500 PRICE TARGET TO 1120 (1033) PENCE - 'HOLD'

----------

BARCLAYS CUTS WEIR GROUP PRICE TARGET TO 1200 (1750) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 400 (550) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 170 (160) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERREXPO PRICE TARGET TO 130 (190) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS WORKSPACE PRICE TARGET TO 930 (980) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS GREAT PORTLAND PRICE TARGET TO 660 (825) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS DERWENT LONDON PRICE TARGET TO 2850 (3720) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES IP GROUP TO 'BUY' ('HOLD') - TARGET 73 (72) PENCE

----------

INVESTEC RAISES KINGFISHER TO 'HOLD' ('SELL') - TARGET 160 (170) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES RESTAURANT GROUP TO 'BUY' ('NEUTRAL')

----------

RBC CUTS HURRICANE ENERGY PRICE TARGET TO 30 (65) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS YOUNG & COS BREWERY PRICE TARGET TO 1230 (1550) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PETRA DIAMONDS PRICE TARGET TO 5 (6) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS GEM DIAMONDS PRICE TARGET TO 40 (50) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HELICAL PRICE TARGET TO 435 (475) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS DRAPER ESPRIT PRICE TARGET TO 487 (727) PENCE - 'BUY'

----------

JEFFERIES CUTS ALLIED MINDS PRICE TARGET TO 56 (99) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.